Light's Criteria — Pleural Fluid Classification
Részletes útmutató hamarosan
Dolgozunk egy átfogó oktatási útmutatón a(z) Light's Criteria (Pleural Fluid) számára. Nézzen vissza hamarosan a lépésről lépésre történő magyarázatokért, képletekért, valós példákért és szakértői tippekért.
Light's Criteria are the most widely validated set of laboratory parameters for distinguishing exudative from transudative pleural effusions — a distinction that fundamentally directs the diagnostic and therapeutic pathway for any patient with pleural fluid. Described by Richard Light in 1972, the criteria use the ratio of pleural fluid to serum protein and LDH (lactate dehydrogenase) to classify the effusion. An effusion is classified as an exudate if any ONE of the three criteria is met: (1) pleural fluid protein/serum protein ratio >0.5; (2) pleural fluid LDH/serum LDH ratio >0.6; (3) pleural fluid LDH exceeding two-thirds of the upper limit of normal for serum LDH. Meeting even one criterion classifies the effusion as an exudate. This approach has a positive predictive value (PPV) for exudate of approximately 98% — meaning almost all true exudates are correctly identified. The sensitivity for detecting exudate is around 98%. However, the specificity is lower (approximately 72–80%), and a well-known clinical limitation is that transudates in patients receiving diuretic therapy are frequently misclassified as exudates (in approximately 20–25% of cases) because diuresis concentrates pleural fluid proteins and LDH. When diuretic-treated patients are suspected of having a transudate despite a positive Light's criterion, the albumin gradient (serum albumin minus pleural fluid albumin) is the recommended correction — a difference of more than 12 g/L still supports transudate regardless of Light's criteria. Transudative effusions most commonly result from heart failure, hepatic cirrhosis, and nephrotic syndrome, and generally do not require diagnostic pleural aspiration beyond initial confirmation. Exudative effusions — due to pneumonia (parapneumonic), malignancy, tuberculosis, pulmonary embolism, or rheumatological disease — require systematic investigation of the underlying cause.
Exudate if ANY ONE criterion is met: 1. Pleural fluid protein / Serum protein > 0.5 2. Pleural fluid LDH / Serum LDH > 0.6 3. Pleural fluid LDH > 2/3 × Upper Limit of Normal serum LDH If none are met → TRANSUDATE If any one or more are met → EXUDATE Diuretic-treated patients: check serum albumin − pleural albumin >12 g/L → still likely transudate
- 1Perform diagnostic pleural aspiration (thoracocentesis) under ultrasound guidance; collect 20–60 mL of fluid into appropriate sample tubes.
- 2Send pleural fluid for: protein, LDH, glucose, pH, cell count and differential, Gram stain and culture, cytology; and serum samples for protein and LDH drawn simultaneously.
- 3Calculate Criterion 1: divide pleural protein by serum protein. If >0.5 → exudate.
- 4Calculate Criterion 2: divide pleural LDH by serum LDH. If >0.6 → exudate.
- 5Criterion 3: obtain the laboratory's upper limit of normal for serum LDH. Multiply by 2/3. If pleural LDH exceeds this value → exudate.
- 6If any criterion is positive, classify as exudate and investigate the cause (cytology, culture, pH for parapneumonic, adenosine deaminase for TB).
- 7If all criteria negative (transudate) in a patient on diuretics, additionally calculate albumin gradient to confirm — serum albumin minus pleural albumin >12 g/L supports transudate.
Exudate — send pleural cytology; consider CT chest; repeat aspiration/biopsy if cytology negative
All three criteria are met, confirming exudate. In an older patient or one with known malignancy, malignant pleural effusion is the priority diagnosis. Pleural fluid cytology has ~60% sensitivity for malignancy; CT-guided or thoracoscopic biopsy may be needed if cytology is negative.
Transudate — treat underlying heart failure with diuretics; diagnostic aspiration usually not required beyond confirmation
All three criteria are below their thresholds, classifying this as a transudate. In the clinical context of bilateral pleural effusions with known heart failure and dependent oedema, no further investigation of the fluid is usually needed. Treatment addresses the cardiac failure.
Diuretic effect: Light's misclassifies ~25% of transudates in diuretic-treated patients; albumin gradient corrects this
Furosemide concentrates pleural fluid proteins, causing the Light's ratio to cross the 0.5 threshold even in a true transudate. The albumin gradient (serum minus pleural albumin >12 g/L) is the recommended correction — here 14 g/L supports transudate. This prevents unnecessary further investigation for exudate in a treated heart failure patient.
Complicated parapneumonic effusion or empyema — chest drain insertion + antibiotics required urgently
The exudate criteria are met with a very high LDH ratio (>2.5), suggesting heavy inflammatory/purulent exudate. A pleural pH below 7.2 and glucose below 2.2 mmol/L are hallmarks of complicated parapneumonic effusion or frank empyema, mandating urgent chest drain insertion rather than repeat aspiration alone.
Emergency medicine and acute medicine — immediate classification of a newly discovered pleural effusion on the same admission to guide whether further investigation or immediate treatment is required., representing an important application area for the Pleural Fluid Lights Criteria in professional and analytical contexts where accurate pleural fluid lights criteria calculations directly support informed decision-making, strategic planning, and performance optimization
Respiratory outpatient clinics — work-up of unexplained or recurrent effusions, particularly in cancer patients where malignant effusion needs to be confirmed or excluded., representing an important application area for the Pleural Fluid Lights Criteria in professional and analytical contexts where accurate pleural fluid lights criteria calculations directly support informed decision-making, strategic planning, and performance optimization
Infectious disease settings — characterising parapneumonic effusions to decide between antibiotics alone versus chest drain insertion based on Light's Criteria plus pH/glucose., representing an important application area for the Pleural Fluid Lights Criteria in professional and analytical contexts where accurate pleural fluid lights criteria calculations directly support informed decision-making, strategic planning, and performance optimization
Cardiology and hepatology — confirming transudative aetiology in bilateral effusions of known heart failure or cirrhosis to avoid unnecessary investigation., representing an important application area for the Pleural Fluid Lights Criteria in professional and analytical contexts where accurate pleural fluid lights criteria calculations directly support informed decision-making, strategic planning, and performance optimization
Oncology — confirming malignant effusions before pleurodesis for symptom palliation in advanced cancer patients., representing an important application area for the Pleural Fluid Lights Criteria in professional and analytical contexts where accurate pleural fluid lights criteria calculations directly support informed decision-making, strategic planning, and performance optimization
Hepatic Hydrothorax
{'title': 'Hepatic Hydrothorax', 'body': "Hepatic hydrothorax occurs in patients with cirrhosis and ascites when peritoneal fluid tracks through diaphragmatic defects into the pleural space. It is typically a transudate. However, if the patient is also on diuretics or has secondary infection (spontaneous bacterial empyema), Light's Criteria may suggest exudate. SAAG (serum-ascites albumin gradient) >11 g/L confirms portal hypertension as the underlying mechanism."}
Malignant Mesothelioma
{'title': 'Malignant Mesothelioma', 'body': "Mesothelioma consistently produces exudative effusions, often large and rapidly re-accumulating after aspiration. Light's Criteria will confirm exudate, but cytology is frequently non-diagnostic (only 30% sensitivity) due to the characteristic cell morphology. Thoracoscopic biopsy with immunohistochemistry (positive calretinin, WT-1; negative CEA, MOC-31) is required for definitive histological diagnosis."}
Bilateral Effusions
{'title': 'Bilateral Effusions', 'body': 'Bilateral effusions strongly suggest transudate (heart failure, hypoalbuminaemia, nephrotic syndrome). If bilateral effusions are found with clinical features atypical for heart failure, or if they are unequal in size, aspiration of the larger effusion is recommended to classify and investigate further. A unilateral exudate on one side with what appears to be a mirror effusion on the other should not be assumed bilateral transudate without sampling.'}
Chylothorax
{'title': 'Chylothorax', 'body': "Chylothorax occurs from thoracic duct disruption (malignancy, trauma, surgery) and produces a milky-appearing exudate rich in triglycerides. Triglyceride >1.24 mmol/L (>110 mg/dL) confirms chylothorax; cholesterol >5.18 mmol/L without elevated triglycerides suggests pseudochylothorax (cholesterol effusion). Light's Criteria classify chylothorax correctly as an exudate. Treatment includes dietary modification (medium-chain triglycerides), octreotide, and thoracic duct ligation or embolisation."}
| Test | Exudate Threshold | Transudate | Additional Significance |
|---|---|---|---|
| Pleural protein / Serum protein | >0.5 | ≤0.5 | Most commonly positive criterion |
| Pleural LDH / Serum LDH | >0.6 | ≤0.6 | Elevated in inflammatory/malignant exudates |
| Pleural LDH vs 2/3 ULN LDH | Pleural LDH > 2/3 ULN | Pleural LDH ≤ 2/3 ULN | High LDH suggests haemothorax or empyema |
| Albumin gradient (corrective) | <12 g/L → exudate | >12 g/L → transudate despite Light's | Use in diuretic-treated patients |
| Pleural pH | <7.2 = complicated | >7.3 = uncomplicated or transudate | Chest drain if pH <7.2 |
| Pleural glucose | <2.2 mmol/L = complicated | >2.2 = uncomplicated | Also low in RA, TB, malignancy |
What is the difference between an exudate and a transudate?
Transudates form when there is an imbalance in hydrostatic and oncotic pressures (heart failure, cirrhosis, nephrotic syndrome) — the pleural membrane itself is healthy and fluid leaks through it passively. Exudates form when the pleural membrane is inflamed, damaged, or disrupted (pneumonia, malignancy, TB, PE, pancreatitis) — causing protein-rich fluid to leak into the pleural space through increased vascular permeability.
Why must serum samples be taken at the same time as pleural aspiration?
Light's Criteria use ratios of pleural to serum values. If serum protein or LDH changes significantly (e.g., if serum albumin falls due to ongoing illness, or LDH rises from haemolysis), the ratios are distorted. Contemporaneous sampling (within hours of the aspiration) ensures the ratios accurately reflect the relationship between pleural fluid and blood at the same point in time.
What should I do when Light's Criteria give a borderline result?
When criteria are borderline (e.g., ratio of 0.48 or 0.52), clinical context is paramount. For patients on diuretics, check the albumin gradient. Consider additional pleural fluid tests: NT-proBNP (elevated in heart failure), cholesterol, triglycerides. If the clinical picture strongly suggests transudate (bilateral effusions, peripheral oedema, normal jugular venous distension) despite borderline exudate criteria, treat the underlying cause and observe.
What is the LDH upper limit of normal (ULN) typically?
The ULN for serum LDH varies by laboratory assay and reference range — typically 200–240 U/L for most assays. Always use the ULN quoted by the specific laboratory performing the test. Two-thirds of the local ULN is then calculated — e.g., 2/3 × 240 = 160 U/L; a pleural LDH exceeding 160 U/L satisfies Criterion 3.
What additional pleural fluid tests are useful beyond Light's Criteria?
pH and glucose (for complicated parapneumonic and empyema: pH <7.2, glucose <2.2 mmol/L). Cytology (for malignancy; sensitivity ~60%). Adenosine deaminase (ADA >40 U/L suggests TB pleuritis). Triglycerides (>1.24 mmol/L suggests chylothorax). Cholesterol (elevated in chronic effusions). Specific cultures (Mycobacterium tuberculosis, bacterial). Amylase (elevated in pancreatitis, oesophageal rupture). This is particularly important in the context of pleural fluid lights criteria calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise pleural fluid lights criteria computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Can pulmonary embolism cause a transudative effusion?
Yes, but rarely. Most PE-associated effusions are exudates caused by pleural infarction and inflammation. Approximately 20% of PE-associated effusions may be transudates caused by elevated venous pressure or atelectasis. A small right-sided transudate is therefore not sufficient to exclude PE as a cause — clinical suspicion and dedicated PE imaging (CTPA or V/Q scan) are required.
What is the sensitivity and specificity of Light's Criteria?
Sensitivity for exudate: approximately 97–98%. Specificity for exudate: approximately 72–80%. Light's Criteria are intentionally designed to be highly sensitive — they will almost never miss a true exudate, but at the cost of misclassifying some transudates (particularly diuretic-treated) as exudates. The albumin gradient correction addresses this common false-positive in clinical practice.
Is thoracoscopy ever needed to classify an effusion?
Thoracoscopy (medical or surgical) is required when: the cause of an exudative effusion remains undiagnosed after cytology and pleural biopsy; when mesothelioma is suspected (requires adequate tissue for histology and immunohistochemistry); or when talc pleurodesis is planned for malignant effusion. Thoracoscopy provides direct visualisation and biopsy of the pleural surface, with sensitivity >90% for malignant mesothelioma.
Pro Tip
Always sample serum for protein and LDH at the time of the pleural aspiration — not on a different day. Even a few hours can introduce significant variability in LDH (which rises in haemolysis or any acute illness). Contemporaneous sampling is the single most important quality control step in Light's Criteria interpretation.
Did you know?
Richard Light derived his criteria as a resident and fellow in the late 1960s and early 1970s by measuring protein and LDH in 150 patients' pleural fluids. The three-criterion approach was designed deliberately to maximise sensitivity (not miss any exudate) at the expense of some specificity — a principled trade-off that has stood the test of 50 years of clinical validation. Light has since published over 500 articles on pleural disease and is widely regarded as the father of modern pleural medicine.
References
- ›Light RW et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507-513.
- ›Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest. 1997;111(4):970-980.
- ›Roberts ME et al. Management of a malignant pleural effusion: BTS pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii32-40.
- ›Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006;73(7):1211-1220.
- ›NICE. Pleural procedures and thoracoscopy (IPG510). Interventional procedures guidance. 2016.